Pharmaceutical unit-dose repackaging and supply chain solutions company Safecor Health, a Vesey Street Capital Partners (VSCP) portfolio company, announced on Monday that it has acquired the US unit-dose packaging business of pharmaceutical company Viatris Inc (NASDAQ:VTRS).
The business was previously called Unit Dose Laboratories (UDL). Established in 1980, it provides unit-dose generic medicines to institutional and long-term care facilities.
The acquisition is expected to be finalised in the first half of 2025, with no immediate action required by customers or partners at this time.
Safecor CEO Mark Saxon, said: "Adding the UDL team, the strong brand recognition, and their capabilities to the Safecor family will further our ongoing goal of providing world-class packaging and supply chain solutions to the manufacturers and health systems we serve. With this addition, we'll immediately increase the number of unit-dose commercial products we offer, and we plan to grow the offering with expanded manufacturer, health system, and wholesaler relationships."
Independent Pharmacy Cooperative signs cooperation agreement with Legacy Pharmacy Group
ILIKOS Consulting partners with Jordan Center for Pharmaceutical Research
Axsome Therapeutics settles patent litigation with Teva over AUVELITY
Breckenridge Pharmaceutical's Everolimus Tablets for Oral Suspension receive US FDA approval
Newbury Pharmaceuticals secures generic approval for pomalidomide in Denmark
Newbury Pharmaceuticals secures generic approval for Bosutinib in Norway
Guangzhou Fermion Technology partners with Simcere Pharmaceutical
Veeda Group rebrands as 'Veeda Lifesciences'
ANI Pharmaceuticals launches generic Motegrity tablets
Hikma Pharmaceuticals USA receives FDA approval for diabetes drug
Full Circles Therapeutics advances non-viral gene editing innovation
Induction Healthcare secures national video solution contract in Ireland
Safecor Health acquires Viatris' US unit-dose packaging business
LOG Pharma Primary Packaging opens new clean room
American Regent launches 30 mL Epinephrine Injection, USP in US